LCM
CRL icon

Logan Capital Management’s Charles River Laboratories CRL Stock Holding History

Logan Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,975
Closed -$2.03M – 327
2025
Q4 		$2.19M Sell
10,975
-2,042
-16% -$370K 0.09% 164
2025
Q3 		$2.04M Buy
13,017
+1,930
+17% +$307K 0.09% 167
2025
Q2 		$1.68M Sell
11,087
-487
-4% -$64.9K 0.08% 172
2025
Q1 		$1.74M Sell
11,574
-10,482
-48% -$1.76M 0.08% 179
2024
Q4 		$4.07M Sell
22,056
-1,674
-7% -$322K 0.17% 127
2024
Q3 		$4.67M Sell
23,730
-275
-1% -$57.1K 0.19% 120
2024
Q2 		$4.96M Sell
24,005
-353
-1% -$80K 0.21% 116
2024
Q1 		$6.6M Buy
24,358
+3,201
+15% +$764K 0.28% 100
2023
Q4 		$5M Sell
21,157
-2,400
-10% -$472K 0.23% 112
2023
Q3 		$4.62M Buy
23,557
+2,832
+14% +$581K 0.23% 112
2023
Q2 		$4.36M Sell
20,725
-2,488
-11% -$495K 0.21% 120
2023
Q1 		$4.68M Buy
23,213
+889
+4% +$201K 0.23% 115
2022
Q4 		$4.86M Sell
22,324
-132
-0.6% -$28.8K 0.25% 104
2022
Q3 		$4.42M Buy
22,456
+1,866
+9% +$403K 0.26% 97
2022
Q2 		$4.41M Sell
20,590
-1,146
-5% -$280K 0.25% 104
2022
Q1 		$6.17M Buy
21,736
+416
+2% +$128K 0.3% 96
2021
Q4 		$8.03M Buy
21,320
+512
+2% +$199K 0.35% 86
2021
Q3 		$8.59M Sell
20,808
-611
-3% -$254K 0.4% 77
2021
Q2 		$7.92M Buy
21,419
+1,689
+9% +$564K 0.37% 81
2021
Q1 		$5.72M Buy
19,730
+1,468
+8% +$408K 0.29% 95
2020
Q4 		$4.56M Buy
+18,262
New +$4.35M 0.23% 109

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Logan Capital Management's CRL Position: Q1 2026 in Review

Logan Capital Management sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 10,975 shares — an estimated $2.03M sold.

Logan Capital Management first reported a position in CRL in Q4 2020 and held it in 21 quarters. The position peaked at $8.59M in Q3 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Logan Capital Management reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Logan Capital Management sold 10,975 Charles River Laboratories shares in Q1 2026, an estimated $2.03M.
  • Logan Capital Management first reported a position in Charles River Laboratories in Q4 2020 and held it in 21 quarters.
  • Logan Capital Management's Charles River Laboratories position peaked at $8.59M in Q3 2021.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.